IRIS
VIALE, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 805
NA - Nord America 703
AS - Asia 460
Continente sconosciuto - Info sul continente non disponibili 74
SA - Sud America 49
AF - Africa 4
Totale 2.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 651
RU - Federazione Russa 490
IT - Italia 212
SG - Singapore 182
CN - Cina 138
HK - Hong Kong 41
BR - Brasile 40
BD - Bangladesh 37
VN - Vietnam 31
CA - Canada 28
DE - Germania 25
FR - Francia 21
GB - Regno Unito 14
NL - Olanda 11
FI - Finlandia 10
IN - India 10
MX - Messico 5
AT - Austria 4
CR - Costa Rica 4
ES - Italia 4
HN - Honduras 4
JP - Giappone 4
GT - Guatemala 3
IE - Irlanda 3
PL - Polonia 3
VE - Venezuela 3
CO - Colombia 2
EC - Ecuador 2
ID - Indonesia 2
IQ - Iraq 2
JM - Giamaica 2
KG - Kirghizistan 2
PK - Pakistan 2
SV - El Salvador 2
UA - Ucraina 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 2.022
Salva come PNG Salva come JPEG
Città #
Singapore 116
Moscow 115
Ashburn 87
San Jose 82
Council Bluffs 46
Milan 44
Hong Kong 40
Dallas 24
Beijing 23
Phoenix 23
Lauterbourg 17
New York 17
Rome 17
Los Angeles 15
Santa Clara 15
Shanghai 14
Orem 12
Boardman 11
Ho Chi Minh City 11
Naples 11
Nuremberg 11
Chicago 10
Hanoi 10
Hefei 9
London 8
Atlanta 7
Chennai 6
Houston 6
Brooklyn 5
Cagliari 5
Denver 5
Helsinki 5
Mexico City 5
Montreal 5
São Paulo 5
Turin 5
Miano 4
North Bergen 4
Queens 4
San José 4
Bari 3
Buffalo 3
Cesano Boscone 3
Charleston 3
Cornaredo 3
Costa de' Nobili 3
Frankfurt am Main 3
Guatemala City 3
Jacksonville 3
Lappeenranta 3
Philadelphia 3
San Pedro Sula 3
St Louis 3
Tokyo 3
Toronto 3
Barnet 2
Bekasi 2
Bergamo 2
Bishkek 2
Bologna 2
Brescia 2
Calgary 2
Conway 2
Dublin 2
Edgewood 2
Falkenstein 2
Florence 2
Fucecchio 2
Garbagnate Milanese 2
Jequié 2
Lachine 2
Laval 2
Lawrence 2
Livorno 2
Manchester 2
Newark 2
Oklahoma City 2
Omemee 2
Ottawa 2
Paris 2
Pisa 2
Poplar 2
Porto Alegre 2
Princeton 2
Seattle 2
The Dalles 2
Vancouver 2
Verona 2
Vinh 2
Warsaw 2
Washington 2
Wolfhagen 2
Adair 1
Addis Ababa 1
Aldie 1
Allentown 1
Amman 1
Amsterdam 1
Andradas 1
Andria 1
Totale 990
Salva come PNG Salva come JPEG
Nome #
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice 196
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer 142
Completion Rate and Positive Results Reporting among Immunotherapy Trials in Breast Cancer, 2004-2023 129
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy 125
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response 124
Timing of Recurrence after Neoadjuvant Chemo-Immunotherapy in Patients with Early-Stage Triple-Negative Breast Cancer 119
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer 90
Neoadjuvant immunotherapy in triple-negative breast cancer: lesson learnt, remaining questions 72
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial 69
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak 69
Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology 68
HER2-Low breast cancer: Pathological and clinical landscape 67
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies 66
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis 54
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer 53
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies 50
From intrinsic to adaptive clusters in breast cancer 47
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies 47
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 46
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials 44
Recent advances in triple negative breast cancer: The immunotherapy era 41
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer 39
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development 39
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review 36
Profile of buparlisib and its potential in the treatment of breast cancer: Evidence to date 35
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review 34
Development and validation of a gene expression-based Breast Cancer Purity Score 34
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy 27
Trastuzumab Biosimilars Setting the Pace for the Provision of a Cost Effective Oncological Care: Regulatory and Clinical Issues 27
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer 26
[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial 22
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice 22
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 20
Diagnostic accuracy of modern imaging following neoadjuvant therapy for breast cancer: a comparative analysis of ultrasound versus [18F] FDG PET/MRI in breast response assessment 16
Totale 2.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.740
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 2 0 0 0 0 0 0 0 0 0 0 0
2023/202419 0 0 0 0 0 0 0 0 0 0 8 11
2024/2025207 29 11 3 14 19 29 28 30 14 8 8 14
2025/20261.314 37 44 21 70 87 118 104 146 474 92 58 63
2026/2027552 82 114 138 218 0 0 0 0 0 0 0 0
Totale 2.095